Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis

BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI) are associated with high morbidity and mortality. More in vitro, in vivo, and clinical data suggest that vancomycin (VAN) or daptomycin (DAP) combination therapy with β-lactams (BL) improves outcomes of MRSA...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Infect Dis Ther
Main Authors: Alosaimy, Sara, Sabagha, Noor L., Lagnf, Abdalhamid M., Zasowski, Evan J., Morrisette, Taylor, Jorgensen, Sarah C. J., Trinh, Trang D., Mynatt, Ryan P., Rybak, Michael J.
Formato: Artigo
Idioma:Inglês
Publicado: Springer Healthcare 2020
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7237588/
https://ncbi.nlm.nih.gov/pubmed/32248513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-020-00292-8
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares